Gender-specific protection from microvessel rarefaction in female hypertensive rats

American Journal of Hypertension

Volumn 11, Issue 8 I, 1998, Pages 998-1005

  Papanek, Paula E ^a,b   Rieder, Mark J ^b   Lombard, Julian H ^b   Greene, Andrew S ^b  

^a MARQUETTE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diet; Gender; High blood pressure; Sodium intake; Sprague Dawley rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENDER; HYPERTENSION; KIDNEY SIZE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM INTAKE;

ANIMALS; BLOOD PRESSURE; FEMALE; HYPERTENSION; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SEX FACTORS; SODIUM, DIETARY;

EID: 0031848394     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00114-9     Document Type: Article

References (44)

1. Kannel WB, Wolf PA, Garrison RJ: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30 year followup. Springfield, MA, National Technical Information Service, Section 34 1987;1-459.
2. American Heart Association: 1993 Heart and Stroke Facts Statistics. Dallas, TX, American Heart Association, 1994.
3. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population. Results from the third national health and nutrition examination survey, 1988-1991. Hypertension 1995;25:305-313.
4. Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-762.
5. Blizzard DA, Peterson WN, Iskandar SS, et al: The effect of a high salt diet and gender on blood pressure, urinary protein excretion and renal pathology in SHR rats. Clin Exp Hypertens [A] 1991;A13:687-697.
6. Calhoun DA, Zhu ST, Chen YF, et al: NaCl in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1995;25:285-289.
7. Crofton JT, Share L, Brooks DP: Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in rats. Clin Exp Hypertens [A] 1989;A11:1249-1261.
8. Ouchi Y, Share L, Crofton JT, et al: Sex difference in the development of deoxycorticosterone-salt hypertension in rat. Hypertension 1987;9:172-177.
9. Papanek PE, Hathaway SJ, Fregly MJ, et al: Effect of estrogen in DOCA/NaCl-induced hypertension in rats. FASEB J 1989;3:A396.
10. Adams MR, Clarkson TB, Kaplan JR, et al: Ovarian secretions and atherosclerosis, in Naftolin F, Gutmann JN, DeCherney AH, Sarrel PM (eds): Ovarian Secretions and Cardiovascular and Neurological Function. New York, Raven, 1990, pp 151-159.
11. Share I, Crofton JT, Ouchi Y: Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension. Am J Med Sci 1988;295:314-319.
12. Stallone JN: Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta. Am J Physiol 1993;265:H2073-H2080.
13. Boegehold MA, Johnson MD, Overbeck HW: Pressure independent arteriolar rarefaction in hypertension. Am J Physiol 1991;261:H83-H87.
14. Bohlen HG: Intestinal microvascular adaptation during maturation of spontaneously hypertensive rats. Hypertension 1983;5:739-745.
15. Greene AS, Lombard JH, Cowley AW, Jr., et al: Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension 1990;15:779-783.
16. Greene AS, Tonellato PJ, Lui J, et al: Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989;256:H126-H131.
17. Hansen-Smith F, Greene AS, Cowley AW, Jr., et al: Structural alterations of microvascular smooth muscle cells in reduced renal mass hypertension. Hypertension 1991;17:902-908.
18. Hutchins PM, Darnell AE: Observation of a decreased number of small arterioles in spontaneously hypertensive rats. Circ Res 1974;34/35(suppl 1):161-165.
19. Ono Z, Prewitt RL, Stacy DL: Arteriolar changes in developing and chronic stages of two-kidney, one clip hypertension. Hypertension 1989;14:36-43.
20. Prewitt RL, Chen IIH, Dowell RF: Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982;243:H243-251.
21. Prewitt RL, Chen IIH, Dowell RF: Microvascular alterations in the one kidney, one-clip renal hypertensive rat. Am J Physiol 1984;246:H728-H732.
22. Sokolova IA, Rodionov IM, Blinkov SM: Rarefaction of capillary network in the brain of rats with induced doca-saline and renal hypertension. Microvasc Res 1981;22:125-126.
23. Stacy DL, Prewitt RL: Attenuated microvascular alterations in coarctation hypertension. Am J Physiol 1989; 256:H213-H221.
24. Chen UH, Prewitt RL, Dowell RF: Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol 1981;241:H306-H310.
25. Henrich HL, Romen W, Heimgartner W, et al: Capillary rarefaction characteristic of the skeletal muscle of hypertensive patients. Klin Wochenschr 1988;66:54-60.
26. Cowley AW Jr., Skelton MM, Papanek PE, et al: Hypertension induced by high salt intake in absence of volume retention in reduced renal mass rats. Am J Physiol 1994;267:H1707-H1712.
27. Papanek PE, Wood CE, Fregly MJ: Role of the sympathetic nervous system in cold-induced hypertension in rats. J Appl Physiol 1991;71:300-306.
28. Rieder MJ, Roman RJ, Greene AS: Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 1997;30(part 1):120-127.
29. Rieder MJ, O'Drobinak DM, Greene AS: A computerized method for determination of microvascular density. Microvasc Res 1995;49:180-189.
30. Crofton JT, Share L: Gonadal hormones modulate desoycorticosterone-salt hypertension in male and female rats. Hypertension 1997;29(part 2):494-499.
31. Hernandez I, Cowley AW, Jr., Lombard JH, et al: Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am J Physiol 1992;263:H664-H667.
32. Greene AS: Life and death in the microcirculation: a role for angiotensin II. Microcirculation (in press).
33. Susie D, Radujkovic R, Kentera D: The mechanism of the antihypertensive action of progesterone: hemodynamic studies in rats with partial nephrectomy salt hypertension. Clin Exp Hypertension A. 1983;5:353-366.
34. Fregly MJ, Fater DC: Prevention of DOCA-induced hypertension in rats by chronic treatment with tryptophan. Clin Exper Pharm Physiol 1986;13:767-776.
35. Henley WN, Fregly MJ, Wilson KM, et al: Physiologic responses to chronic dietary tyrosine supplementation in DOCA-salt-treated rats. Pharmacology 1986;33:334-347.
36. Fernandez LA, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105: 141-145.
37. Le Noble FA, Hekking JW, Van Straaten HW, et al: Angiotensin II stimulates angiogenesis in the chorioallantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305-306.
38. Munzenmaier DH, Greene AS: Alterations in microvessel growth by infusions of subpressor angiotensin. Hypertension 1996;27(part 2):760-765.
39. Wang DH, Prewitt RL: Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
40. Papanek PE, Rieder MJ, Greene AS: Reversal of exercise-induced angiogenesis by captopril (abst). Microcirculation 1996;3:100.
41. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain function estrogen receptor. Circulation 1984;89:1943-1950.
42. Shan J, Resnick LM, Liu Qy, et al: Vascular effects of 17β-estradiol in male Sprague-Dawley rats. Am J Physiol 1994;266:H967-H973.
43. Gagliardi A, Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 1993;53:533-535.
44. Sar M, Stumpf WE: Combined autoradiography and immunohistochemistry for simultaneous localization of radioactively labeled steroid hormones and antibodies in the brain. J Histochem Cytochem. 1981;29:161-166.